CTS.AU Ceretas Limited

Healthcare Medical Care Facilities Australian Securities Exchange
0.9200 AUD
Close of Oct 30, 2026
0.4300 1.11
Market cap
AUD 65.7M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is CTS.AU undervalued?

Graham number

The Graham number of Ceretas Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ceretas Limited fundamental analysis

No fundamental analysis for Ceretas Limited yet.

Ceretas Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ceretas Limited

Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined w…

Full company profile